Last quarter (Q ), XORTX Therapeutics Inc's total revenue was C$―, a decrease of ― from the same quarter last year. In Q, XORTX Therapeutics Inc's net income was C$2.70M. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	C$ 5.88M	C$ 5.88M	C$ 13.39M	C$ 3.65M	C$ 1.30M	C$ 565.97K
Operating Income	C$ -5.88M	C$ -5.88M	C$ -13.39M	C$ -3.65M	C$ -1.30M	C$ -565.97K
Net Non Operating Interest Income Expense	C$ 253.54K	C$ 253.54K	C$ 137.57K	C$ 5.60K	C$ -13.51K	C$ -37.21K
Other Income Expense	C$ -3.47M	C$ -3.47M	C$ -3.21M	C$ 2.00M	C$ 29.41K	C$ -26.40K
Pretax Income	C$ -2.16M	C$ -2.16M	C$ -9.49M	C$ -1.65M	C$ -1.28M	C$ -629.58K
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -2.16M	C$ -2.16M	C$ -9.49M	C$ -1.65M	C$ -1.28M	C$ -629.58K
Basic EPS	C$ -0.52	C$ -1.09	C$ -0.71	C$ -0.17	C$ -0.19	C$ -0.01
Diluted EPS	C$ -0.52	C$ -1.09	C$ -0.71	C$ -0.17	C$ -0.19	C$ -0.01
Basic Average Shares	C$ 45.01M	C$ 1.98M	C$ 13.32M	C$ 9.85M	C$ 6.66M	C$ 62.92M
Diluted Average Shares	C$ 45.01M	C$ 1.98M	C$ 13.32M	C$ 9.85M	C$ 6.66M	C$ 62.92M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 5.88M	C$ 5.88M	C$ 13.39M	C$ -3.65M	C$ 1.30M	C$ 565.97K
Net Income From Continuing And Discontinued Operation	C$ -2.16M	C$ -2.16M	C$ -9.49M	C$ -1.65M	C$ -1.28M	C$ -629.58K
Normalized Income	C$ -1.59M	C$ -1.59M	C$ -6.97M	C$ -1.21M	C$ -1.31M	C$ -603.18K
Interest Expense	-	-	-	-	C$ 13.51K	C$ 37.21K
EBIT	C$ -2.16M	C$ -2.16M	C$ -9.49M	C$ -1.65M	C$ -1.27M	C$ -592.36K
EBITDA	C$ -2.02M	C$ -2.02M	C$ -9.41M	C$ -1.63M	C$ -1.25M	C$ -572.46K

Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing